UNSPSC 51152044: Silperisone

This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R16SK8726X. European Medicines Agency schedules Silperisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10521MIG. Silperisone generally arises in the molecular formula C15H24FNSI.

UNSPSC 51152044 Silperisone is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The single recent opportunity in the data—Seminole County, Florida's IFB 60459723LAS—is for Naloxone and Safe Drug Deactivation Systems, which diverges substantially from the pharmaceutical classification. The county sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. While Seminole County is pursuing this procurement through standard IFB mechanisms with fixed-fee pricing and standard commercial insurance and E-Verify compliance requirements, the opportunity itself does not align to the silperisone category and appears to reflect a tagging mismatch rather than genuine activity under the code.

Recent state and local sourcing under this Commodity code does not support a meaningful characterization of issuing-body types, geographic concentration, or workload. The single posted opportunity originated in Florida but addresses overdose-response and drug-waste management rather than silperisone procurement. State and local procurement professionals evaluating this code should treat the apparent absence of on-topic activity as a signal; the code shows no clear recent demand for silperisone-specific goods or services within the state and local market as of mid-2026.